0001352413-18-000008.txt : 20180921 0001352413-18-000008.hdr.sgml : 20180921 20180921120238 ACCESSION NUMBER: 0001352413-18-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180919 FILED AS OF DATE: 20180921 DATE AS OF CHANGE: 20180921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Capone Mark Christopher CENTRAL INDEX KEY: 0001352413 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 181080979 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-09-19 0 0000899923 MYRIAD GENETICS INC MYGN 0001352413 Capone Mark Christopher 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 President & C.E.O. Common Stock 2018-09-19 4 A 0 165000 0.0 A 486150 D Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. By: Richard Marsh For: Mark C Capone 2018-09-21